Skip to main navigation Skip to search Skip to main content

Risk of Cardiovascular Events in Patients With Type 2 Diabetes and Metabolic Dyslipidemia Without Prevalent Atherosclerotic Cardiovascular Disease.

  • University of California, San Francisco
  • Kaiser Permanente
  • Regeneron
  • Real-World Evidence and Clinical Outcomes, Sanofi, Bridgewater, NJ

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalThe American Journal of Medicine
Volume133
Issue number2
DOIs
StatePublished - Feb 1 2020
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Endocrinology, Diabetes, and Metabolism
  • Internal Medicine

Cite this